Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Treating iron overload.

Camaschella C.

N Engl J Med. 2013 Jun 13;368(24):2325-7. doi: 10.1056/NEJMcibr1304338. No abstract available.

PMID:
23758239
[PubMed - indexed for MEDLINE]
2.

An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.

Schmidt PJ, Toudjarska I, Sendamarai AK, Racie T, Milstein S, Bettencourt BR, Hettinger J, Bumcrot D, Fleming MD.

Blood. 2013 Feb 14;121(7):1200-8. doi: 10.1182/blood-2012-09-453977. Epub 2012 Dec 6.

PMID:
23223430
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Inhibiting the hepcidin inhibitor for treatment of iron overload.

Silvestri L.

Blood. 2013 Feb 14;121(7):1068-9. doi: 10.1182/blood-2012-12-472597. No abstract available.

PMID:
23411732
[PubMed - indexed for MEDLINE]
Free Article
4.

[Diagnosis and treatment of genetic haemochromatosis].

Milman NT.

Ugeskr Laeger. 2013 Apr 15;175(16):1109-12. Review. Danish.

PMID:
23651749
[PubMed - indexed for MEDLINE]
5.

Hepcidin and Hfe in iron overload in beta-thalassemia.

Gardenghi S, Ramos P, Follenzi A, Rao N, Rachmilewitz EA, Giardina PJ, Grady RW, Rivella S.

Ann N Y Acad Sci. 2010 Aug;1202:221-5. doi: 10.1111/j.1749-6632.2010.05595.x. Review.

PMID:
20712796
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Current approach to hemochromatosis.

Brissot P, Troadec MB, Bardou-Jacquet E, Le Lan C, Jouanolle AM, Deugnier Y, Loréal O.

Blood Rev. 2008 Jul;22(4):195-210. doi: 10.1016/j.blre.2008.03.001. Epub 2008 Apr 21. Review.

PMID:
18430498
[PubMed - indexed for MEDLINE]
7.

Liver iron concentrations and urinary hepcidin in beta-thalassemia.

Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, Nemeth E.

Haematologica. 2007 May;92(5):583-8.

PMID:
17488680
[PubMed - indexed for MEDLINE]
Free Article
8.

Prospects for a hepcidin mimic to treat β-thalassemia and hemochromatosis.

Parrow NL, Gardenghi S, Rivella S.

Expert Rev Hematol. 2011 Jun;4(3):233-5. doi: 10.1586/ehm.11.22. No abstract available.

PMID:
21668388
[PubMed - indexed for MEDLINE]
9.

Hepcidin in beta-thalassemia.

Nemeth E.

Ann N Y Acad Sci. 2010 Aug;1202:31-5. doi: 10.1111/j.1749-6632.2010.05585.x.

PMID:
20712769
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Review article: the iron overload syndromes.

Siddique A, Kowdley KV.

Aliment Pharmacol Ther. 2012 Apr;35(8):876-93. doi: 10.1111/j.1365-2036.2012.05051.x. Epub 2012 Mar 4. Review.

PMID:
22385471
[PubMed - indexed for MEDLINE]
11.

Striking the target in iron overload disorders.

Finberg KE.

J Clin Invest. 2013 Apr 1;123(4):1424-7. doi: 10.1172/JCI68889. Epub 2013 Mar 25.

PMID:
23524962
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Hepcidin: the Grail of iron metabolism].

Loréal O, Brissot P.

Gastroenterol Clin Biol. 2002 Aug-Sep;26(8-9):805-7. Review. French. No abstract available.

PMID:
12434091
[PubMed - indexed for MEDLINE]
Free Article
13.

HJV hemochromatosis, iron overload, and hypogonadism in a Brazilian man: treatment with phlebotomy and deferasirox.

Santos PC, Cançado RD, Pereira AC, Chiattone CS, Krieger JE, Guerra-Shinohara EM.

Acta Haematol. 2010;124(4):204-5. doi: 10.1159/000321493. Epub 2010 Nov 12. No abstract available.

PMID:
21071928
[PubMed - indexed for MEDLINE]
14.

[Iron overload. Diagnosing and treating prior to complications].

Deugnier Y, Bourel M.

Rev Prat. 2006 Dec 15;56(19):2109-10. French. No abstract available.

PMID:
17416046
[PubMed - indexed for MEDLINE]
15.

[Disturbed iron balance in hemochromatosis and inflammation. Discovery of the iron regulating hormone hepcidin gives new explanations].

Stål P, Gåfvels M, Eggertsen G, Holmström P.

Lakartidningen. 2007 May 30-Jun 3;104(22):1696-700. Review. Swedish. No abstract available.

PMID:
17601319
[PubMed - indexed for MEDLINE]
16.

Hepcidin biology and therapeutic applications.

Nemeth E.

Expert Rev Hematol. 2010 Apr;3(2):153-5. doi: 10.1586/ehm.10.1.

PMID:
21083458
[PubMed - indexed for MEDLINE]
17.

Association of hepcidin promoter c.-582 A>G variant and iron overload in thalassemia major.

Andreani M, Radio FC, Testi M, De Bernardo C, Troiano M, Majore S, Bertucci P, Polchi P, Rosati R, Grammatico P.

Haematologica. 2009 Sep;94(9):1293-6. doi: 10.3324/haematol.2009.006270.

PMID:
19734422
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Exploring the role of hepcidin, an antimicrobial and iron regulatory peptide, in increased iron absorption in beta-thalassemia.

Breda L, Gardenghi S, Guy E, Rachmilewitz EA, Weizer-Stern O, Adamsky K, Amariglio N, Rechavi G, Giardina PJ, Grady RW, Rivella S.

Ann N Y Acad Sci. 2005;1054:417-22.

PMID:
16339690
[PubMed - indexed for MEDLINE]
19.

[Post transfusionnal iron overload].

Rose C.

Rev Prat. 2006 Dec 15;56(19):2141-5. French.

PMID:
17416052
[PubMed - indexed for MEDLINE]
20.

Iron-chelating therapy for transfusional iron overload.

Musallam KM, Taher AT.

N Engl J Med. 2011 Apr 14;364(15):1476; author reply 1477. doi: 10.1056/NEJMc1101838#SA2. No abstract available.

PMID:
21488787
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk